CCAB Welcomes Mr. Robert Verhagen as New CEO

Ontario Industry Updates
Written By Guest User

The Centre for the Commercialization of Antibodies and Biologics (CCAB) Board of Directors is pleased to announce the appointment of Mr. Robert Verhagen as the organization’s new Chief Executive Officer, effective November 1, 2017.

As CCAB’s new CEO, Mr. Verhagen will provide his strategic direction to position CCAB as a leader in the commercialization of academic discoveries in the biologics field and in the advancement of this biotech sector in Canada.

For the full press release on the CCAB site click here

Guest User
Previous

Ontario Announces Dr. Molly Shoichet As First Chief Scientist
Next

CAAP Company: Conavi Medical, China Grand Pharmaceutical & Healthcare Enter Distribution Agreement for Minimally Invasive Imaging Technologies in China